Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 9th August 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Racing body advises against injectable Omeprazole
Samples of the injectable Omeprazole 100mg/ml (BOVA UK) were found to contain low levels of testosterone.

Product found to contain low levels of testosterone

Injectable Omeprazole should not be used in racehorses due to the presence of testosterone, the British Horseracing Authority (BHA) has advised.

BHA encouraged trainers to discuss alternative treatments with their veterinary surgeons.

Analytical laboratory LGC looked at a number of products containing Omeprazole. Samples of the injectable Omeprazole 100mg/ml (BOVA UK) were found to contain low levels of testosterone.

No oral preparations were found to contain testosterone or any other anabolic steroid.

BHA warned that the possession, use or attempted use of this product could amount to a breach of the Rules of Racing.

Presence of testosterone over the permitted threshold in a sample could result in a 14-month suspension from racing and a 12-month stand down from racing for the horse, as well as other penalties for the Responsible Person.

Trainers and other industry participants were advised to remove the product from all licensed premises and not to administer the product to a thoroughbred from birth until permanent retirement from racing. 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk